$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Analysis of golodirsen side effects, adverse reactions and medication safety recommendations
2026-02-01 22:25:32
Check Details
An analysis of the clinical medication regimens and precautions for different patients with Vidicitomab (Aidexi)
2026-02-01 22:25:32
Check Details
Isatuximab is produced and developed by which company?
2026-02-01 22:25:32
Check Details
Whether capivasertib tablets (capivasertib) has been included in the medical insurance and reimbursement policy
2026-02-01 22:25:32
Check Details
The latest market price and reference cost of Guselkumab in 2026
2026-02-01 22:25:32
Check Details
Tenapanor reimbursement ratio and patient cost analysis
2026-02-01 22:25:32
Check Details
What is revumenib-REVUFORJ and analysis of its pharmacological effects
2026-02-01 22:25:32
Check Details
Why is Guanfacine not recommended to be taken casually and its possible risks
2026-02-01 22:25:32
Check Details
Detailed description of pacritinib market price and drug purchase channels
2026-02-01 22:25:32
Check Details
Should Letermovir (Premin) be taken before or after meals and the best time to take it?
2026-02-01 22:25:32
Check Details
Can Etrasimod-Velsipity cure ulcerative colitis and its clinical efficacy
2026-02-01 22:25:32
Check Details
Who should not take Lusutrombopag?
2026-02-01 22:25:32
Check Details
1
2
...
2355
2356
2357
2358
2359
2360
2361
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma